Drug establishmentActive, Registered FY2026FDA warning letter on file

Yiling Pharmaceutical Ltd

Yiling Pharmaceutical Ltd is an FDA-registered drug establishment (FEI 3011640199) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2024-10-11) was classified OAI. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Mar 27, 2025
CGMP/Finished Pharmaceuticals/Adulterated

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3011640199
Address
No.36 Zhujiang Road, ,
Establishment type
Drug establishment
Products / operations
Manufacturing
Registration status
Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file
Oct 11, 2024 · Official Action Indicated (OAI)
Jun 15, 2018 · Voluntary Action Indicated (VAI)
Form 483 observations
None on file

Questions

Is Yiling Pharmaceutical Ltd registered with the FDA?

Yes. Yiling Pharmaceutical Ltd is an FDA-registered drug establishment (FEI 3011640199) in . Its current registration status is Active, Registered FY2026.

Has Yiling Pharmaceutical Ltd received an FDA warning letter?

Yes. FDA issued a warning letter to Yiling Pharmaceutical Ltd; the most recent is dated Mar 27, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Yiling Pharmaceutical Ltd do?

Yiling Pharmaceutical Ltd's FDA-registered operations are: Manufacturing.

Related facilities

Source: FDA public data · status as of 2026-06-06

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.